A detailed history of Invenomic Capital Management LP transactions in Salesforce, Inc. stock. As of the latest transaction made, Invenomic Capital Management LP holds 39,250 shares of CRM stock, worth $13.5 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
39,250
Holding current value
$13.5 Million
% of portfolio
0.61%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$238.42 - $276.53 $9.36 Million - $10.9 Million
39,250 New
39,250 $10.7 Million
Q4 2022

Feb 14, 2023

BUY
$128.21 - $165.27 $20.5 Million - $26.4 Million
159,680 Added 296.87%
213,467 $28.3 Million
Q3 2022

Nov 14, 2022

BUY
$143.84 - $191.27 $1.14 Million - $1.52 Million
7,951 Added 17.35%
53,787 $7.74 Million
Q2 2022

Aug 15, 2022

BUY
$155.6 - $218.85 $7.13 Million - $10 Million
45,836 New
45,836 $7.57 Million

Others Institutions Holding CRM

About Salesforce, Inc.


  • Ticker CRM
  • Exchange NYSE
  • Sector Technology
  • Industry Software—Application
  • Shares Outstandng 1,000,000,000
  • Market Cap $344B
  • Description
  • Salesforce, Inc. provides customer relationship management technology that brings companies and customers together worldwide. Its Customer 360 platform empowers its customers to work together to deliver connected experiences for their customers. The company's service offerings include Sales to store data, monitor leads and progress, forecast opp...
More about CRM
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.